Literature DB >> 17299269

Long-lasting expression of HO-1 delays progression of type I diabetes in NOD mice.

Ming Li1, Stephen Peterson, Daniel Husney, Muneo Inaba, Kequan Guo, Attallah Kappas, Susumu Ikehara, Nader G Abraham.   

Abstract

Heme oxygenase-1 (HO-1) is crucial in regulating oxidative injury. The present study was designed to assess whether HO-1 upregulation by cobalt protoporphyrin IX (CoPP) moderates or prevents the diabetic state in non-obese diabetic (NOD) mice, an animal model for Type 1 diabetes (T1D). HO-1 expression and HO activity were upregulated in the pancreas by the intermittent administration of CoPP. This was associated with decreases in blood glucose and pancreatic O2-, but increased pAKT and BcL-XL and cell survival. A considerable number of beta cells were preserved in the islets of CoPP-treated NOD mice, while none were found in untreated diabetic mice. The number of CD11c+ dendritic cells was decreased in the pancreas of CoPP-treated NOD mice (p < 0.05). These novel findings provide a link between the increase in HO-1 and a decrease in infiltrated CD11c+ dendritic cells, and suggest that induction of HO-1 activity can be used to enhance cell survival and moderate the diabetic state in T1D.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17299269     DOI: 10.4161/cc.6.5.3917

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  19 in total

1.  Naive human T cells are activated and proliferate in response to the heme oxygenase-1 inhibitor tin mesoporphyrin.

Authors:  Trevor D Burt; Lillian Seu; Jeffrey E Mold; Attallah Kappas; Joseph M McCune
Journal:  J Immunol       Date:  2010-10-04       Impact factor: 5.422

2.  ApoA1: mimetic peptide reverses adipocyte dysfunction in vivo and in vitro via an increase in heme oxygenase (HO-1) and Wnt10b.

Authors:  Luca Vanella; Ming Li; DongHyun Kim; Giuseppe Malfa; Lars Bellner; Tomoko Kawakami; Nader G Abraham
Journal:  Cell Cycle       Date:  2012-02-15       Impact factor: 4.534

3.  Mice with hyperbilirubinemia due to Gilbert's syndrome polymorphism are resistant to hepatic steatosis by decreased serine 73 phosphorylation of PPARα.

Authors:  Terry D Hinds; Peter A Hosick; Shujuan Chen; Robert H Tukey; Michael W Hankins; Andrea Nestor-Kalinoski; David E Stec
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-01-17       Impact factor: 4.310

4.  Induction of hemeoxygenase-1 reduces glomerular injury and apoptosis in diabetic spontaneously hypertensive rats.

Authors:  Ahmed A Elmarakby; Jessica Faulkner; Babak Baban; Mohamed A Saleh; Jennifer C Sullivan
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-28

5.  Successful modulation of type 2 diabetes in db/db mice with intra-bone marrow--bone marrow transplantation plus concurrent thymic transplantation.

Authors:  Ming Li; Nader G Abraham; Luca Vanella; Yuming Zhang; Muneo Inaba; Naoki Hosaka; Sho-Ichi Hoshino; Ming Shi; Yoko Miyamoto Ambrosini; M Eric Gershwin; Susumu Ikehara
Journal:  J Autoimmun       Date:  2010-12       Impact factor: 7.094

Review 6.  Therapeutic potential of HO-1 in autoimmune diseases.

Authors:  Bao-Zhu Li; Biao Guo; Hai-Yan Zhang; Juan Liu; Sha-Sha Tao; Hai-Feng Pan; Dong-Qing Ye
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

Review 7.  Heme oxygenase: the key to renal function regulation.

Authors:  Nader G Abraham; Jian Cao; David Sacerdoti; Xiaoying Li; George Drummond
Journal:  Am J Physiol Renal Physiol       Date:  2009-07-01

8.  Identification of crassin acetate as a new immunosuppressant triggering heme oxygenase-1 expression in dendritic cells.

Authors:  Hironori Matsushima; Hiroaki Tanaka; Norikatsu Mizumoto; Akira Takashima
Journal:  Blood       Date:  2009-04-28       Impact factor: 22.113

9.  Heme oxygenase-1: its therapeutic roles in inflammatory diseases.

Authors:  Hyun-Ock Pae; Hun-Taeg Chung
Journal:  Immune Netw       Date:  2009-02-28       Impact factor: 6.303

10.  Upregulation of heme oxygenase-1 combined with increased adiponectin lowers blood pressure in diabetic spontaneously hypertensive rats through a reduction in endothelial cell dysfunction, apoptosis and oxidative stress.

Authors:  Jian Cao; George Drummond; Kazuyoshi Inoue; Komal Sodhi; Xiao Ying Li; Shinji Omura
Journal:  Int J Mol Sci       Date:  2008-12-01       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.